Equities analysts expect Physicians Realty Trust (NYSE:DOC) to report $84.14 million in sales for the current quarter, according to Zacks. Six analysts have made estimates for Physicians Realty Trust’s earnings. The lowest sales estimate is $76.70 million and the highest is $92.00 million. Physicians Realty Trust reported sales of $70.01 million in the same quarter last year, which would suggest a positive year over year growth rate of 20.2%. The firm is scheduled to issue its next quarterly earnings results before the market opens on Friday, November 3rd.

According to Zacks, analysts expect that Physicians Realty Trust will report full-year sales of $84.14 million for the current year, with estimates ranging from $306.26 million to $348.48 million. For the next year, analysts expect that the firm will post sales of $386.94 million per share, with estimates ranging from $308.12 million to $445.17 million. Zacks Investment Research’s sales calculations are a mean average based on a survey of research firms that follow Physicians Realty Trust.

Physicians Realty Trust (NYSE:DOC) last posted its earnings results on Thursday, August 3rd. The real estate investment trust reported $0.24 EPS for the quarter, topping the Zacks’ consensus estimate of $0.23 by $0.01. The business had revenue of $76.60 million during the quarter, compared to analyst estimates of $80.48 million. Physicians Realty Trust had a return on equity of 1.75% and a net margin of 11.51%. The company’s quarterly revenue was up 43.9% compared to the same quarter last year. During the same quarter last year, the company earned $0.22 EPS.

Several equities analysts have issued reports on the stock. Jefferies Group LLC reaffirmed a “hold” rating and issued a $19.00 price target (up from $18.00) on shares of Physicians Realty Trust in a report on Friday, September 22nd. Zacks Investment Research upgraded Physicians Realty Trust from a “strong sell” rating to a “hold” rating in a report on Tuesday, September 12th. BidaskClub upgraded Physicians Realty Trust from a “hold” rating to a “buy” rating in a report on Friday, June 23rd. Morgan Stanley raised Physicians Realty Trust from an “underweight” rating to an “equal weight” rating and set a $18.00 price objective for the company in a research report on Monday, July 24th. Finally, KeyCorp reissued a “hold” rating on shares of Physicians Realty Trust in a research report on Tuesday, September 12th. Six analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $20.58.

Shares of Physicians Realty Trust (DOC) opened at 17.56 on Tuesday. The company’s 50 day moving average price is $18.32 and its 200 day moving average price is $19.37. The stock has a market capitalization of $2.77 billion, a PE ratio of 75.04 and a beta of 0.53. Physicians Realty Trust has a 52-week low of $17.12 and a 52-week high of $21.85.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 18th. Stockholders of record on Tuesday, October 3rd will be issued a $0.23 dividend. This represents a $0.92 dividend on an annualized basis and a dividend yield of 5.24%. The ex-dividend date is Monday, October 2nd. Physicians Realty Trust’s dividend payout ratio is presently 400.02%.

Institutional investors have recently added to or reduced their stakes in the stock. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in Physicians Realty Trust by 5.5% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 8,098 shares of the real estate investment trust’s stock valued at $161,000 after buying an additional 425 shares during the last quarter. Chicago Partners Investment Group LLC increased its holdings in Physicians Realty Trust by 603.8% in the 2nd quarter. Chicago Partners Investment Group LLC now owns 9,086 shares of the real estate investment trust’s stock worth $177,000 after buying an additional 7,795 shares during the period. Pinnacle Associates Ltd. acquired a new position in Physicians Realty Trust in the 2nd quarter worth approximately $205,000. Quantbot Technologies LP increased its holdings in Physicians Realty Trust by 69.8% in the 1st quarter. Quantbot Technologies LP now owns 11,729 shares of the real estate investment trust’s stock worth $233,000 after buying an additional 4,821 shares during the period. Finally, Profund Advisors LLC increased its holdings in Physicians Realty Trust by 6.8% in the 2nd quarter. Profund Advisors LLC now owns 11,569 shares of the real estate investment trust’s stock worth $233,000 after buying an additional 733 shares during the period. 94.21% of the stock is owned by hedge funds and other institutional investors.

WARNING: “Zacks: Analysts Anticipate Physicians Realty Trust (DOC) Will Post Quarterly Sales of $84.14 Million” was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this article on another website, it was copied illegally and reposted in violation of international copyright legislation. The original version of this article can be read at https://www.thecerbatgem.com/2017/10/03/zacks-analysts-anticipate-physicians-realty-trust-doc-will-post-quarterly-sales-of-84-14-million.html.

Physicians Realty Trust Company Profile

Physicians Realty Trust (the Trust) is a real estate investment trust. Physicians Realty L.P. is the operating partnership of the Trust. The Trust and its operating partnership are engaged in acquiring, developing, owning and managing healthcare properties that are leased to physicians, hospitals and healthcare delivery systems.

Get a free copy of the Zacks research report on Physicians Realty Trust (DOC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Physicians Realty Trust (NYSE:DOC)

Receive News & Stock Ratings for Physicians Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physicians Realty Trust and related stocks with our FREE daily email newsletter.